Relative risks of having pharmaceutical or medical device industry sponsorship in the programme of the last medical societies’ annual conference
| Main model | Stratified analysis | |||||||
|---|---|---|---|---|---|---|---|---|
| All sample (n=131) | Only services (n=42) | Only clinical (n=59) | Only surgical (n=30) | |||||
| Crude RR | Adjusted RR | Crude RR | Adjusted RR | Crude RR | Adjusted RR | Crude RR | Adjusted RR | |
| Ethical code | 1.39 (1.23 to 1.57) | 1.22 (1.01 to 1.48) | 1.74 (1.33 to 2.28) | 0.66 (0.42 to 1.04) | 1.23 (1.07 to 1.41) | 1.28 (1.04 to 1.59) | 1.29 (1.03 to 1.63) | 1.33 (0.88 to 2.01) |
| Statute | 1.16 (0.91 to 1.47) | 1.17 (0.89 to 1.53) | 1.67 (0.94 to 2.94) | 1.48 (0.81 to 2.70) | 0.86 (0.67 to 1.12) | 0.86 (0.59 to 1.23) | 1.18 (0.74 to 1.89) | 1.28 (0.74 to 2.19) |
| No annual financial report on website | 1.29 (0.67 to 2.48) | 1.22 (0.72 to 2.08) | 1.28 (0.31-0.32) | 1.80 (0.65 to 4.94) | 1.71 (0.42 to 6.96) | 1.65 (0.33 to 8.19) | 1.17 (0.50 to 2.73) | 0.95 (0.67 to 1.32) |
| Dimension of society | 1.14 (1.06 to 1.22) | 1.13 (1.05 to 1.21) | 1.29 (1.09 to 1.53) | 1.28 (1.02 to 1.61) | 1.09 (0 to 98 to 1.21) | 1.11 (0.01 to 6.03) | 1.08 (0.99 to 1.18) | 1.08 (0.25 to 1.67) |
| Type of society | ||||||||
| Services | 1 | 1 | – | – | – | – | – | – |
| Clinical | 1.40 (1.05 to 1.87) | 1.22 (0.89 to 1.78) | – | – | – | – | – | – |
| Surgical | 1.31 (0.94 to 1.84) | 1.32 (0.94 to 1.84) | – | – | – | – | – | – |
Bold typeface indicates significant results.